Featured Articles
Latest Articles
Article
New Type of Memory Identified by Behavioral Researchers
New research indicates the existence of an unconscious memory store that supports predictions made by one of the leading theories of consciousness, called the global workspace theory.
Article
Risk Assessment and Expert Review of N-Nitrosamine Contaminants
In this article, David Elder discusses the identification of N-nitrosamine impurities in valsartan drug substances products in mid-2018 and highlights the regulatory response, sources of contamination and analytical methods used for identifying nitrosamines.
Article
Why Antibody Testing Should Be Our Next Tool in the Fight Against COVID-19
In this article, Keir Lewis explores how antibody testing can help provide invaluable data that can be used to inform the next stage of the vaccination program rollout.
Article
European Proteomics Infrastructure Consortium – Providing Access
The European Proteomics Infrastructure Consortium providing Access, or EPIC-XS, started in January 2019. It brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. In this article, Martina O'Flaherty provides an overview of some of the successes of the consortium so far.
Article
COVID-19 Vaccine Safety in Pregnancy
What are the benefits and risks for pregnant persons when it comes to COVID-19 and the vaccines, and does the benefit of the vaccine outweigh the risk of infection? Amber Schmidtke explores the scientific data available.
Article
Measuring Real-Time Cell Therapy Potency With Bioelectronic Assays
As CAR T cells become more popular, the value of potency monitoring will become clearer. Assays that use bioelectrodes to measure the potency of immune cells offer a new approach in cell therapy development.
Article
Examining Risk–Benefit Profiles for Vaccines
In this article, David Elder, explores the risk–benefit profiles for various COVID-19 vaccines and discusses the steps taken by regulatory agencies in response to the occurrence of rare blood clotting events associated with the Oxford–AstraZeneca vaccine.
Article
Why mRNA Vaccines Could Be a Game Changer
In this article, Amber Schmidtke explores why mRNA vaccines might chart our path to a safer, healthier future.
Article
Gut Microbiome Changes Identified After Spinal Cord Injury
A pilot study led by Professor Phillip Popovich has placed focus on how traumatic SCI might impact the gut microbiome – the population of microbes inhabiting the digestive tract. We spoke to study author Ahmed Zayed to find out more.
Article
Changing Up the Route of Vaccine Administration
In this article, we discuss the various routes of vaccine administration and highlight key innovations in this space.
Advertisement